| Name | 1-(4-chlorophenyl)-3-(2,3-dihydro-1H-inden-5-ylsulfonyl)urea |
|---|---|
| Synonyms |
N-(5-Indansulfonyl)-N'-(4-chlorophenyl)urea
SULOFENUR Sulofenurum [INN-Latin] N-[[(4-chlorophenyl)amino]carbonyl]-indan-5-sulfonamide N-(Indanyl-5-sulfonyl)-N'-(4-chlorophenyl)urea N-([(4-chlorophenyl)amino]carbonyl)-2,3-dihydro-1H-indene-5-sulfonamide 1-(p-Chlorophenyl)-3-(5-indanylsulfonyl)urea |
| Density | 1.449g/cm3 |
|---|---|
| Molecular Formula | C16H15ClN2O3S |
| Molecular Weight | 350.82000 |
| Exact Mass | 350.04900 |
| PSA | 83.65000 |
| LogP | 4.88380 |
| Index of Refraction | 1.656 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| HS Code | 2935009090 |
|---|
|
~76%
110311-27-8 |
| Literature: Howbert; Grossman; Crowell; Rieder; Harper; Kramer; Tao; Aikins; Poore; Rinzel; Grindey; Shaw; Todd Journal of Medicinal Chemistry, 1990 , vol. 33, # 9 p. 2393 - 2407 |
|
~86%
110311-27-8 |
| Literature: Howbert; Grossman; Crowell; Rieder; Harper; Kramer; Tao; Aikins; Poore; Rinzel; Grindey; Shaw; Todd Journal of Medicinal Chemistry, 1990 , vol. 33, # 9 p. 2393 - 2407 |
|
~%
110311-27-8 |
| Literature: Eli Lilly and Company Patent: US5116874 A1, 1992 ; |
| Precursor 4 | |
|---|---|
| DownStream 0 | |
| HS Code | 2935009090 |
|---|---|
| Summary | 2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0% |